![Page 1: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/1.jpg)
HIV treatment is::
Primary care with “benefits”
![Page 2: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/2.jpg)
the scoop : :
• Guidelines Rule
• treat anyone who is willing
• compliance is KING
• beware of the drugs
![Page 3: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/3.jpg)
DHHS Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected
Adults and Adolescents
www.aidsinfo.nih.gov
![Page 4: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/4.jpg)
![Page 5: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/5.jpg)
who to treat : :
• CD4 < 200, 350, 500, what next?
• treatment is prevention– serodiscordant couples– pregnancy
• think of the viral load of the community
![Page 6: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/6.jpg)
who to treat::
Clinical Category CD4 Count Recommendation
AIDS defining illness or severe symptoms*
Any value TREAT
Pregnancy, HIVAN,tx HBV co-infection
Any value TREAT
Asymptomatic <350/mm3 TREAT
Asymptomatic 350-500/mm3 55% strongly 45% moderately
Asymptomatic >500/mm3 50% favored50% optional
*http://www.aegis.com/topics/definition.html
![Page 7: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/7.jpg)
HPTN 052
![Page 8: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/8.jpg)
who not to treat::
• anyone who is not going to take their medicine AKA: Non-compliance
It is really more like Why Not to treat
– when you know the details of a situation, the situation is unchanged. when you don’t know the details of a situation, it still is unchanged.
Zen proverb
![Page 9: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/9.jpg)
how to treat::
• is this person sick? • No
![Page 10: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/10.jpg)
how to treat::
• is this person sick?– CD4 < 200– CD4 < 50– Symptoms i.e. opportunistic infection
![Page 11: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/11.jpg)
CD4 < 200
• At risk for PCP • GI symptoms?• Candidiasis?• Rash?• Needs meds as soon as ready
![Page 12: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/12.jpg)
CD4 < 50
• This group of patients is TROUBLE• Must look for OI’s, frequently more than 1• IRIS is common• TB is bad in this group, skin test not reliable• 1/3 mortality in first year after diagnosis
![Page 13: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/13.jpg)
what to use::
![Page 14: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/14.jpg)
therapy naïve regimens::
• NNRTI based-regimen– efavirenz/tenofovir/emtricitabine
• PI based-regimens– atazanavir/ritonavir/tenofovir/emtricitabine– darunavir/ritonavir/tenofovir/emtricitabine
• Integrase Inhibitor based-regimen– raltegravir/tenofovir/emtricitabine
• Pregnancy– lopinavir/ritonavir/zidovudine/lamivudine
![Page 15: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/15.jpg)
1. Fusion
2. Reverse transcription
3. Integration
4. Transcription
5. Assembly of virus particles
6. Budding of virus particles
how it works::
![Page 16: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/16.jpg)
efavirenz• Category D, neural tube defects
– Recommend 2 birth control methods, negative HCG prior to initiation
• Caution with use in prior psychiatric disease• False + cannabinoid & benzos on screening• AEs: Drowsiness, dizziness, insomnia, abnormal
dreaming, agitation• Take at bedtime on an empty stomach to ↓CNS SE
• If need to eat, avoid taking with fatty food • Rash is possible, as long as no other symptoms keep
taking meds but need medical eval ASAP
![Page 17: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/17.jpg)
efavirenz rash
![Page 18: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/18.jpg)
efavirenz rash
![Page 19: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/19.jpg)
tenofovir/emtricitabine ::
• Generally well tolerated: gas, headaches• Fanconi’s syndrome and renal insufficiency
• Check urinalysis every 6 months; PO4 suggested• Hyperpigmentation possible• Osteopenia • Active against HBV
• Know pt’s status and counsel accordingly• Once daily with or without food• Both agents need renal adjustment when <50ml/min
![Page 20: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/20.jpg)
Fanconi’s Syndrome::
• The Fanconi syndrome refers to a generalized impairment in proximal tubular function leading to urinary wasting of compounds normally reabsorbed in the proximal tubule. The consequences are hypophosphatemia (which can lead to osteomalacia), renal glucosuria, hypouricemia, aminoaciduria, and proximal renal tubular acidosis due to bicarbonate loss in the urine (Up To Date).
![Page 21: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/21.jpg)
Preferred Protease Inhibitors
![Page 22: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/22.jpg)
atazanavir/ritonavir
• Interacts with PPIs, antacids, & H2A• All available OTC
• Increased unconjugated bili• Scleral icterus or jaundice
• Take with food• Less impact on lipids• Prolonged PR interval, asymptomatic 1st degree
AV block• 3 total: 1 atazanavir, 1 ritonavir, 1
tenofovir/emtricitabine
![Page 23: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/23.jpg)
darunavir/ritonavir
• CAUTION with sulfa allergy (not contraindicated)• Take with food• Rash 10%• Abdominal pain• Headache• Hepatotoxicity• Diarrhea (usually less than Kaletra)• 4 tablets total: 1 ritonavir, 2 darunavir, 1
tenofovir/emtricitabine
![Page 24: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/24.jpg)
preferred integrase inhibitor::
![Page 25: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/25.jpg)
raltegravir::• Taken BID• Minimal drug interactions
• PPI increases raltegravir• AEs: diarrhea, nausea, headache, and pyrexia• Increased ALT, AST, CPK possible
• Myopathy and rhabdomyolysis reported• 3 tablets total: 1 raltegravir BID, 1
tenofovir/emtricitabine
![Page 26: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/26.jpg)
compliance ::
• The tendency to yield to others especially in a weak or subservient way
• The strain of an elastic body expressed as a function of the force applied to it
• How many doses have you missed in the last month?
• How many have you taken late?
![Page 27: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/27.jpg)
compliance ::
• How many doses have you missed in the last month?
• How many have you taken late?
• WHY?• How can we improve this?
![Page 28: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/28.jpg)
compliance ::
• 95% compliance is MINIMUM required to receive maximal drug benefit
• 19/20 days or once per month for a once daily drug
• compare self-report to pill counts• works great with diabetes too
![Page 29: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/29.jpg)
beware of the drugs::
![Page 30: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/30.jpg)
bone disease::
• Osteoppenia• Avascular Necrosis• Vitamin D metabolism impacted• Osteoporosis down the road?
![Page 31: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/31.jpg)
AVN on the left
![Page 32: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/32.jpg)
energy metabolism complications::
• Lactic acidosis• Lipoatrophy• Fat redistribution• Hyperlipidemia• Glucose intolerance• Hypertriglyceridemia
![Page 33: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/33.jpg)
Lipoatrophy
![Page 34: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/34.jpg)
renal complications::
• Fanconi’s syndrome• Stone disease
![Page 35: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/35.jpg)
Fanconi’s Syndrome::
• The Fanconi syndrome refers to a generalized impairment in proximal tubular function leading to urinary wasting of compounds normally reabsorbed in the proximal tubule. The consequences are hypophosphatemia (which can lead to osteomalacia), renal glucosuria, hypouricemia, aminoaciduria, and proximal renal tubular acidosis due to bicarbonate loss in the urine (Up To Date).
![Page 36: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/36.jpg)
Fanconi’s labs::
• Creat 1.0 ->1.4->1.2• PO4 3.0 ->2.1->2.9
• Urine glucose 150-> neg• Urine protein 100 mg/dl-> neg
![Page 37: Primary Care Perspective on HIV Treatment Bloomquist](https://reader036.vdocuments.net/reader036/viewer/2022070317/556af91dd8b42a2a4f8b49f1/html5/thumbnails/37.jpg)
resources::
• consult with US – AFCAHN, phone, email• Guidelines• Warmline is AWESOME• Community providers